Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Atkore To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in Atkore between February 1, 2024 and February 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, April 22, 2025 /PRNewswire ...

Asia Value & Moat Stocks is a research service for value investors seeking Asia-listed stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e. buying assets at a discount e.g. net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e. buying earnings power at a discount in great companies like "Magic Formula" stocks, high-quality businesses, hidden champions and wide moat compounders). Sign up here to get starte ...

American Resources Corporation (AREC) , through its stake in ReElement Technologies Corporation, has announced the expansion of its operational equipment to address the rising demand for rare earth oxides sourced within the United States. Leading this effort is ReElement, which is dedicated to establishing a reliable and secure domestic supply chain for critical minerals. Utilizing a scalable, highly efficient and adaptable refinery platform, ReElement delivers both light and heavy magnet-grade rare earth o ...

Northern Trust Corporation (NTRS) came out with quarterly earnings of $1.90 per share, beating the Zacks Consensus Estimate of $1.85 per share. This compares to earnings of $1.70 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.70%. A quarter ago, it was expected that this company would post earnings of $2.02 per share when it actually produced earnings of $2.26, delivering a surprise of 11.88%.Over the last four quarters, th ...

So far, 2025 has proven to be a terrible year in the stock markets, and nearly all of it has to do with the economic fallouts of the start of President Trump's second term in the White House: tariff escalations, a possible coming recession, andWith combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. He has been a regula ...

I rate AllianceBernstein Holding L.P. (NYSE: AB ) as a Buy, for capital appreciation focused investors who are looking for long-term buy and hold investments. AB will declare Q1 earnings on April 24 th and is widely expectedDavid A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As an investor entrepreneur, David invests in stocks, bonds, options, ETFs, REITs, real estate, closed end funds and alternative investment funds such as hedge funds and pri ...

Amazon (AMZN -2.90%) is scheduled to report its highly anticipated quarterly financial results on May 1.*Stock prices used were the afternoon prices of April 19, 2025. The video was published on April 21, 2025. ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

West Pharmaceutical Services (WST) is scheduled to release first-quarter 2025 results on April 24, before the opening bell. In the last reported quarter, the company delivered an earnings beat of 4.00%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, delivering an average surprise of 8.33%.Q1 EstimatesCurrently, the Zacks Consensus Estimate for revenues is pegged at $686.5 million, indicating a decline of 1.3% from the year-ago period’s level. The consensus mark for ear ...